Clinical effect of Langladyam Loham and Kaishor Guggul in Vatarakta.

A Randomized controlled clinical trial to compare the efficacy of Langladyam Loham with Kaishor Guggul in the management of Vatarakta. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098719

Enrollment

120

Registered

2025-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M103- Gout due to renal impairment

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having signs and symptoms or Vatarakta such as Sandhi Shula (pain), Sandhi Shotha (Swelling), Sparshaashatva (Tenderness), Twak Vaivarnya (Discolouration of skin. 2. Patient from age group between 20-65 years old, irrespective of their sex, religion geographical area. 3. Patient having uric acid level greater than 7 mg/dl in male ^ 6 mg/dl in female.

Exclusion criteria

Exclusion criteria: 1. Patient having severe disorder like renal disorder-acute and chronic renal failure, poly nephritic syndrome, Liver disorder, Liver cirrhosis, Hepatitis, Neurological Disorder. 2. Patient having sexual transmitted disease and immunosuppressant disorder. 3. Lactating Mothers, Pregnant Women. 4. Patient having Rheumatoid arthritis, Psoriatic arthritis , any joint replacement surgery, and any chronic illness.

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Langladyam Loham with Kaishor Guggul in the management of Vatarakta, To evaluate the efficacy of Langladyam Loham on biochemical markers and to assesst the side effect if any.Timepoint: Duration of the study- 36 months. Duration of treatment: 30 days follow up 7th day, 14th day,21st day and 31st day	—

Secondary

Measure	Time frame
To study adverse effect if any. To assess the efficacy of Langladyam Loham And Kaishor Guggul on biochemical markersTimepoint: Duration of the study- 36 months. Duration of treatment: 30 days follow up 7th day, 14th day,21st day and 31st day	—

Countries

India

Contacts

Public ContactDr Pritesh Jaiswal

PDEAs College of Ayurved And Research Center Pune

medhamaheshjoshi@gmail.com9881465798

Outcome results